Strax

Autospela

The future of CTCL therapy

2 Visningar • 08/09/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Julia Jane Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham, Birmingham, UK, shares her views on the future of cutaneous T-cell lymphoma (CTCL) therapy, highlighting the unmet need for more efficacious therapies and to determine the optimal sequencing of therapies. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela